Ethos Technologies Inc. (LIFE) Stock Price & Analysis
Ethos Technologies Inc. (LIFE) closed at USD 38.76 on Thursday, October 15, 2026, down 0.54% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 38.97; the Oct 15, 2026 session ranged USD 36.99–39.3 on volume of 1,113,679 shares. Market capitalization is $2.52B, with a 52-week range of USD 9.45–42.55 (NMS). Source: Nexqual, retrieved October 16, 2026 at 05:21 UTC.
Also available as compact Markdown for AI agents: nexqual.com/LIFE.md
Key facts (LIFE)
- Last four reported quarters (through Jun 30, 2026): revenue $566M, net income -$116M (-20.5% margin), free cash flow $89.6M (SEC filings).
- Analysts: Buy (mean 1.89 on a 1–5 scale) (9 analysts), mean target USD 37.5 (range 32–43).
- Total return with dividends: 1Y +130.0% vs S&P 500 +18.1%; 5Y +157.5% vs S&P 500 +85.1%.
- Next earnings: 2026-11-02, EPS estimate USD 0.35, revenue estimate $169M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (LIFE)
| USD | FY2025 | FY2025 | TTM |
|---|---|---|---|
| Revenue | $255M | $388M | $566M |
| Gross profit | $248M | $381M | — |
| Operating income | $48.7M | $72.9M | -$114M |
| Net income | $48.8M | $71.2M | -$116M |
| EPS (diluted) | $0.85 | $1.22 | — |
| Free cash flow | -$11.7M | $34.7M | $89.6M |
| Gross margin | 97.4% | 98.3% | — |
| Operating margin | 19.1% | 18.8% | -20.1% |
| Net margin | 19.2% | 18.4% | -20.5% |
| Revenue growth | — | +52.0% | — |
| Cash + short-term investments | $103M | $126M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (LIFE)
P/S 4.5x · P/FCF 28.1x · P/B 5.3x · FCF yield 3.56% · Earnings yield -4.61%
Analysts (LIFE)
Consensus Buy (mean 1.89 on a 1–5 scale), 9 analysts; mean target USD 37.5 (low 32, high 43).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-12 | Citizens | Target raised | Market Outperform | $33 → $40 |
| 2026-10-01 | JP Morgan | Downgrade | Overweight → Neutral | $37 |
| 2026-08-04 | Citigroup | Target raised | Buy | $27 → $33 |
| 2026-08-04 | Citizens | Target raised | Market Outperform | $27 → $33 |
| 2026-08-04 | Baird | Target raised | Outperform | $26 → $32 |
| 2026-08-04 | Barclays | Target raised | Overweight | $27 → $37 |
| 2026-07-13 | JP Morgan | Target raised | Overweight | $21.5 → $23 |
Total return (dividends reinvested) (LIFE)
| 1Y (from 2026-01-29) | 5Y (from 2026-01-26) | |
|---|---|---|
| Total return | +130.0% | +157.5% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | — | — |
| Volatility (annualized) | 89.1% | 111.6% |
| Max drawdown | -50.1% (May 2026→Jun 2026) | -47.5% (May 2026→Jun 2026) |
Key Statistics (as of October 16, 2026 at 05:21 UTC)
| Price | USD 38.76 |
|---|---|
| Change | ▼ 0.54% (down) |
| Previous Close | USD 38.97 |
| Open | USD 38.64 |
| Day Range | USD 36.99 – 39.3 |
| 52-Week Range | USD 9.45 – 42.55 |
| Volume | 1,113,679 shares |
| Market Cap | $2.52B |
| Exchange | NMS |
Technical Analysis (LIFE)
Nexqual's technical model rates LIFE "BUY" based on 5 bullish and 1 bearish signals across 127 daily candles, as of October 16, 2026 at 05:21 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 57.11 (neutral) |
| vs SMA50 | Above (USD 36.15) |
| MACD | 0.81 (positive) |
Analyst Ratings (LIFE)
Wall Street analysts rate LIFE "Buy" based on 9 analysts, with a mean price target of USD 37.5 (range USD 32–43), per Nexqual as of October 16, 2026 at 05:21 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 9 |
| Mean Target | USD 37.5 |
| High Target | USD 43 |
| Low Target | USD 32 |
| Buy / Hold / Sell | 8 / 1 / 0 |
Earnings (LIFE)
| Next Earnings Date | 2026-11-02 |
|---|---|
| EPS Estimate | USD 0.35 |
| Revenue Estimate | $169.02M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.53 vs est 0.28 ▲ beat |
| 2026-03-31 | USD 0.38 vs est 0.47 ▼ miss |
| 2025-12-31 | USD 0.42 vs est 0.4 ▲ beat |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Financials & Fundamentals (LIFE)
| Total Revenue | $586.53M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +113.40% |
| Gross Margin | +98.13% |
| Operating Margin | +9.56% |
| Profit Margin | -18.15% |
| ROE | -26.11% |
| Debt / Equity | 0 |
| Current Ratio | 1.52 |
| Total Cash | $168.32M |
| Total Debt | $1.77M |
| Free Cash Flow (fiscal year ended Dec 2025, SEC 10-K) | $34.73M (9.0% of revenue) |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Financial Health Score (LIFE)
Nexqual rates Ethos Technologies Inc.'s overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 05:21 UTC.
| Growth | Strong — Revenue +113% YoY (latest Q) |
|---|---|
| Profitability | Mixed — Operating margin 10% |
| Balance Sheet | Strong — $168M cash vs $2M debt, net cash position |
| Cash Flow | Solid — FCF $35M (FY ended Dec 2025, 10-K), 9% margin |
| Efficiency | Critical — ROE -26%, ROA -11.1% |
Ownership (LIFE)
| Insider Ownership | +8.66% |
|---|---|
| Institutional Ownership | +46.02% |
| Shares Outstanding | 41.71M |
| Float | 29.67M |
| Short % of Float | +10.99% |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Leadership (LIFE)
Ethos Technologies Inc. is led by Peter George Colis (age 35), Co-Founder, CEO & Chair of Board of Directors, per Nexqual as of October 16, 2026 at 05:21 UTC.
| Co-Founder, CEO & Chair of Board of Directors | Peter George Colis (age 35) |
|---|---|
| Co-Founder, President & Director | Lingke Wang (age 34) |
| Chief Technology Officer | Vipul Sharma (age 45) |
| Senior Vice President of Finance | Kunal Mehta (age 43) |
| Chief Financial Officer | Christopher Michael Capozzi (age 47) |
Major Backers & Investors (LIFE)
Notable institutional backers of Ethos Technologies Inc. include Alphabet Inc., Softbank Group Corporation, T. Rowe Price, according to Nexqual as of October 16, 2026 at 05:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Alphabet Inc. | 11.48% |
| Softbank Group Corporation | 9.92% |
| T. Rowe Price | 7.43% |
| Divisadero Street Capital Management, LP | 5.18% |
| Capital Group | 4.17% |
| SmallCap World Fund Inc | 4.17% |
| Glade Brook Capital Partners LLC | 2.72% |
| TR PRICE-Price (T.Rowe) U.S. Small-Cap Value Equity Trust | 1.56% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 3.04% |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
From Ethos Technologies Inc.'s Latest SEC 10-K Filing (filed 2026-03-17)
Key Strengths & Strategy (as disclosed to the SEC)
- Ethos Technologies Inc. provides third-party administrator services for insurance policies in the United States.
- The company offers Ethos, a three-sided technology platform that serves an ecosystem of consumers, agents, and carriers.
- It also provides term life insurance, whole life insurance, and indexed universal life insurance products, as well as wills and estate planning, and supplemental health insurance products.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GSHD | Goosehead Insurance, Inc. | USD 45.6 | ▲ 2.61% |
| NP | Neptune Insurance Holdings Inc. | USD 29.45 | ▲ 0.96% |
| CRVL | CorVel Corp. | USD 80.29 | ▲ 1.88% |
| ARX | Accelerant Holdings | USD 19.76 | ▼ 0.05% |
| BWIN | The Baldwin Insurance Group, In | USD 31.93 | ▲ 0.19% |
| CRD-A | Crawford & Company | USD 12.41 | ▼ 1.59% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:21 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt